Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

23andMe Holding Co. (ME)

2.77   -0.02 (-0.72%) 09-24 15:18
Open: 2.74 Pre. Close: 2.79
High: 2.83 Low: 2.635
Volume: 4,691,833 Market Cap: 1,251(M)
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.83 - 2.85 2.85 - 2.87
Low: 2.59 - 2.61 2.61 - 2.63
Close: 2.73 - 2.77 2.77 - 2.8

Technical analysis

as of: 2022-09-23 4:25:49 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.09     One year: 4.71
Support: Support1: 2.63    Support2: 2.19
Resistance: Resistance1: 3.5    Resistance2: 4.03
Pivot: 3.19
Moving Average: MA(5): 2.92     MA(20): 3.21
MA(100): 3.02     MA(250): 5.02
MACD: MACD(12,26): -0.2     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 9.1     %D(3): 7.2
RSI: RSI(14): 36.7
52-week: High: 13.68  Low: 2.11
Average Vol(K): 3-Month: 3,960 (K)  10-Days: 4,818 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ME ] has closed above bottom band by 7.3%. Bollinger Bands are 11.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 24 Sep 2022
My rich friend never Venmo's me back for our nights out - Slate

Sat, 24 Sep 2022
Splatoon 3’s multi-layered grind has me completely hooked - Digital Trends

Sat, 24 Sep 2022
How to use Hold for me - Android Police

Sat, 24 Sep 2022
Part of me leaves with Federer, says emotional Nadal - Reuters

Fri, 23 Sep 2022
Trilogy-Lovin' Me/To Make A Woman Feel Wanted/Peace Of Mind - Lefsetz Letter

Fri, 23 Sep 2022
JP Saxe Releases Emotional Breakup Song 'When You Think of Me' After Julia Michaels Split - PEOPLE

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 260 (M)
Shares Float 255 (M)
% Held by Insiders 4.9 (%)
% Held by Institutions 38.2 (%)
Shares Short 32,360 (K)
Shares Short P.Month 32,340 (K)

Stock Financials

EPS -0.61
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.88
Profit Margin (%) -95.7
Operating Margin (%) -102.1
Return on Assets (ttm) -17.7
Return on Equity (ttm) -35
Qtrly Rev. Growth 8.8
Gross Profit (p.s.) 0.51
Sales Per Share 1.06
EBITDA (p.s.) -0.99
Qtrly Earnings Growth 0
Operating Cash Flow -195 (M)
Levered Free Cash Flow -75 (M)

Stock Valuations

PE Ratio -4.61
PEG Ratio 0
Price to Book value 1.46
Price to Sales 2.59
Price to Cash Flow -3.69

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.